A major goal pursued by Pylotum is to study the origin of H. pylori related gastric cancer to develop novel means of prevention, risk stratification, diagnosis and therapeutic interventions for gastric cancer patients. Our ongoing trials will help to determine the impact of H. pylori eradication on gastric cancer development as well as to identify novel biomarkers and future therapeutic targets to treat gastric tumors. An experienced international interdisciplinary team and a state-of-the-art infrastructure ensure the success of our research projects.

资助机构： 德国联邦教育和研究部（BMBF）  |  中华人民共和国科学技术部  |  北京市科学技术委员会